BCDA · BioCardia Inc
United States · RS rating 29 · As of 2026-10-14
| Price | 0.93 USD |
|---|---|
| 1-day change | -6.4% |
| RS rating (overall / 1M / 3M / 12M) | 29 / 9 / 84 / 18 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 30 / 8 / 49 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +38.1% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +40.6% |
| Market cap (USD) | $12.8M |